Radiolabeled Peptides for Molecular Imaging of Apoptosis

Mona Mosayebnia1, Maliheh Hajiramezanali2, Soraya Shahhosseini2

  • 1Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Insights

This review explores radiopeptides targeting apoptosis, a key process in diseases and cancer therapy. These agents offer sensitive, single-cell level imaging for early disease detection and treatment monitoring.

Area of Science:

  • Biomedical imaging
  • Molecular imaging
  • Radiochemistry

Background:

  • Apoptosis, or programmed cell death, is crucial for health and disease.
  • Tracking apoptosis aids in diagnosing cardiovascular/neurodegenerative diseases and monitoring cancer therapy.
  • Key mediators in apoptosis pathways are targets for imaging and therapeutic agents.

Purpose of the Study:

  • To review radiopeptides targeting apoptosis.
  • To discuss their diverse mechanisms of action.
  • To highlight their potential in molecular imaging.

Main Methods:

  • Literature review of radiopeptides targeting apoptosis.
  • Analysis of their targeting mechanisms.
  • Evaluation of their imaging characteristics.

Main Results:

  • Radiopeptides combine nuclear imaging sensitivity with peptide scaffold advantages.
  • Targeted radiopeptides enable sensitive, single-cell level apoptosis detection.
  • Various radiopeptides utilize different mechanisms to target apoptotic pathways.

Conclusions:

  • Radiopeptides are promising tools for apoptosis imaging.
  • They facilitate early disease detection and therapy monitoring.
  • Further research into their characteristics can optimize their clinical application.